Author(s)

Misty Gamble^1,2, Elizabeth Tocci³, Jennifer A. DeSimone^2,4

¹Department of Melanoma and Cutaneous Oncology, MedStar Washington Hospital Center, Washington DC, USA.
²Department of Dermatology, MedStar Georgetown University Hospital, Washington DC, USA.
³University of Massachusetts Medical School, Worcester, USA.
⁴Melanoma and Skin Oncology, INOVA Fairfax Hospital, Fairfax, USA.

The treatment of advanced stage MF is especially challenging as single agent overall response rates are in the 35% range and chronic recurrence is the rule. The treatment of CTCL across all stages of disease is aimed at the goal of achieving and sustaining remission. Increasingly, low dose total skin electron beam therapy (TSEBT) is being utilized as a skin directed component in combination therapy for advanced stage CTCL. Researchers are seeking to better define the utility of low dose TSEBT as a method of debulking skin disease while simultaneously treating other disease compartments and in combination with sustained maintenance therapies of both the skin directed and systemic varieties. Data exists showing the efficacy of low dose TSEBT in early and advanced disease. There is also data documenting prolonged treatment responses with TSEBT plus adjuvant skin directed therapies such as PUVA and topical nitrogen mustard. Emerging data examining the role of low dose TSEBT in the prestem cell transplant preparation is also promising. This brief review summarizes the utility of low dose TSEBT in multiagent treatment regimens in CTCL.

Cutaneous T-Cell Lymphoma, Mycosis Fungoides, Total Skin Electron Beam Therapy, Hematopoietic Stem Cell Transplantation

Gamble, M. , Tocci, E. and DeSimone, J. (2014) Low Dose Total Skin Electron Beam Radiation in Cutaneous T-Cell Lymphoma: Review. Journal of Cancer Therapy, 5, 1372-1379. doi: 10.4236/jct.2014.514138.